Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IVD Medical Holding Limited ( (HK:1931) ) has issued an update.
IVD Medical Holding Limited has announced significant progress in its strategic initiatives, including the establishment of a wholly-owned subsidiary in New York and the launch of a US stablecoin license application. These developments are part of the company’s broader strategy to implement the IVDNewCo Exchange Ecosystem, which aims to tokenize real-world medical assets and create a compliant financial infrastructure for stablecoin issuance and trading. The recent signing of the Genius Act by the US President and the introduction of Hong Kong’s Stablecoins Ordinance are expected to accelerate the development of the global stablecoin market, potentially benefiting IVD Medical’s operations and positioning in the industry.
More about IVD Medical Holding Limited
IVD Medical Holding Limited operates in the medical industry, focusing on high-tech medical innovative drug assets. The company is actively engaged in constructing a Web3 Exchange Ecosystem, known as IVDNewCo Exchange, which integrates Web3 technology to enhance the liquidity and financing efficiency of global medical innovative drug assets.
Average Trading Volume: 286,962
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.78B
For detailed information about 1931 stock, go to TipRanks’ Stock Analysis page.